*Review* **Evolving Technologies in Gastrointestinal Microbiome Era and Their Potential Clinical Applications**

#### **Abraham Ajayi 1 Tolulope Jolaiya 2 and Stella Smith 1,3,\***


Received: 18 June 2020; Accepted: 4 August 2020; Published: 7 August 2020

**Abstract:** The human gastrointestinal microbiota (GIM) is a complex and diverse ecosystem that consists of community of fungi, viruses, protists and majorly bacteria. The association of several human illnesses, such as inflammatory bowel disease, allergy, metabolic syndrome and cancers, have been linked directly or indirectly to compromise in the integrity of the GIM, for which some medical interventions have been proposed or attempted. This review highlights and gives update on various technologies, including microfluidics, high-through-put sequencing, metabolomics, metatranscriptomics and culture in GIM research and their applications in gastrointestinal microbiota therapy, with a view to raise interest in the evaluation, validation and eventual use of these technologies in diagnosis and the incorporation of therapies in routine clinical practice.

**Keywords:** gastrointestinal; microbiota; technology; therapy; high-throughput
